Remdesivir Gets Full FDA Approval as Coronavirus Treatment
Share
[aggregation-styles]
The Hill
The Food and Drug Administration (FDA) has granted full approval to the antiviral drug remdesivir to treat COVID-19, manufacturer Gilead announced Thursday.
FDA initially granted emergency use authorization for remdesivir in May, which allowed doctors and hospitals to use the drug to treat hospitalized patients without a full approval.
It showed modest results in reducing the hospitalizations of patients with severe cases of COVID-19. Remdesivir is administered in a hospital setting through an IV.
Read More →
The Hill
The Food and Drug Administration (FDA) has granted full approval to the antiviral drug remdesivir to treat COVID-19, manufacturer Gilead announced Thursday.
FDA initially granted emergency use authorization for remdesivir in May, which allowed doctors and hospitals to use the drug to treat hospitalized patients without a full approval.
It showed modest results in reducing the hospitalizations of patients with severe cases of COVID-19. Remdesivir is administered in a hospital setting through an IV.
Read More →
By Nathaniel Weixel | 22 Oct 2020
RELATED TOPICS:
Categories
Latest
Videos
World /
4 minutes ago
Zelenskyy Says He’ll Meet With Trump Over the Weekend
Opinion /
25 minutes ago
After Ditching the Penny, US Should Eliminate $50 and $100 Bills
50 minutes ago
Fresno Unified Is Hiring. Which Positions Are Open?
Local /
52 minutes ago




